Showing 1 - 11 results of 11 for search 'Emily E. Ricotta', query time: 0.05s Refine Results
  1. 1
    CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018

    CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018 by Emily E. Ricotta, D. Rebecca Prevots, Kenneth N. Olivier

    Published 2022-04-01
    Get full text
    Article
  2. 2
    Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida.

    Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida. by Sydney L Foote, Ettie M Lipner, D Rebecca Prevots, Emily E Ricotta

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida

    Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida by Sydney L. Foote, Ettie M. Lipner, D. Rebecca Prevots, Emily E. Ricotta

    Published 2021-01-01
    Get full text
    Article
  4. 4
    COVID-19 risk perception and vaccine acceptance in individuals with self-reported chronic respiratory or autoimmune conditions

    COVID-19 risk perception and vaccine acceptance in individuals with self-reported chronic respiratory or autoimmune conditions by Brianna A. Smith, Emily E. Ricotta, Jennifer L. Kwan, Nicholas G. Evans

    Published 2023-05-01
    Get full text
    Article
  5. 5
    Hospital-based antibiotic use in patients with Mycobacterium avium complex

    Hospital-based antibiotic use in patients with Mycobacterium avium complex by Emily E. Ricotta, Kenneth N. Olivier, Yi Ling Lai, D. Rebecca Prevots, Jennifer Adjemian

    Published 2018-11-01
    Get full text
    Article
  6. 6
    Extrapulmonary Nontuberculous Mycobacteria Infections in Hospitalized Patients, United States, 2009–2014

    Extrapulmonary Nontuberculous Mycobacteria Infections in Hospitalized Patients, United States, 2009–2014 by Emily E. Ricotta, Jennifer Adjemian, Rebekah A. Blakney, Yi Ling Lai, Sameer S. Kadri, D. Rebecca Prevots

    Published 2021-03-01
    Get full text
    Article
  7. 7
    Associations between ideational variables and bed net use in Madagascar, Mali, and Nigeria

    Associations between ideational variables and bed net use in Madagascar, Mali, and Nigeria by J. Douglas Storey, Stella O. Babalola, Emily E. Ricotta, Kathleen A. Fox, Michael Toso, Nan Lewicky, Hannah Koenker

    Published 2018-04-01
    Get full text
    Article
  8. 8
    Bronchiectasis-associated infections and outcomes in a large, geographically diverse electronic health record cohort in the United States

    Bronchiectasis-associated infections and outcomes in a large, geographically diverse electronic health record cohort in the United States by Samantha G Dean, Rebekah A Blakney, Emily E Ricotta, James D Chalmers, Sameer S Kadri, Kenneth N Olivier, D Rebecca Prevots

    Published 2024-04-01
    Get full text
    Article
  9. 9
    Mycobacterial Testing Trends, United States, 2009–2015

    Mycobacterial Testing Trends, United States, 2009–2015 by Samantha G. Dean, Emily E. Ricotta, Jonathan Fintzi, Yi Ling Lai, Sameer S. Kadri, Kenneth N. Olivier, Adrian Zelazny, D. Rebecca Prevots

    Published 2020-09-01
    Get full text
    Article
  10. 10
    Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005–2019

    Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005–2019 by Rebekah A. Blakney, Emily E. Ricotta, Timothy B. Frankland, Stacey Honda, Adrian Zelazny, Katrin D. Mayer-Barber, Samantha G. Dean, Dean Follmann, Kenneth N. Olivier, Yihe G. Daida, D. Rebecca Prevots

    Published 2022-08-01
    Get full text
    Article
  11. 11
    An immune-based biomarker signature is associated with mortality in COVID-19 patients

    An immune-based biomarker signature is associated with mortality in COVID-19 patients by Michael S. Abers, Ottavia M. Delmonte, Emily E. Ricotta, Jonathan Fintzi, Danielle L. Fink, Adriana A. Almeida de Jesus, Kol A. Zarember, Sara Alehashemi, Vasileios Oikonomou, Jigar V. Desai, Scott W. Canna, Bita Shakoory, Kerry Dobbs, Luisa Imberti, Alessandra Sottini, Eugenia Quiros-Roldan, Francesco Castelli, Camillo Rossi, Duilio Brugnoni, Andrea Biondi, Laura Rachele Bettini, Mariella D’Angio’, Paolo Bonfanti, Riccardo Castagnoli, Daniela Montagna, Amelia Licari, Gian Luigi Marseglia, Emily F. Gliniewicz, Elana Shaw, Dana E. Kahle, Andre T. Rastegar, Michael Stack, Katherine Myint-Hpu, Susan L. Levinson, Mark J. DiNubile, Daniel W. Chertow, Peter D. Burbelo, Jeffrey I. Cohen, Katherine R. Calvo, John S. Tsang, NIAID COVID-19 Consortium, Helen C. Su, John I. Gallin, Douglas B. Kuhns, Raphaela Goldbach-Mansky, Michail S. Lionakis, Luigi D. Notarangelo

    Published 2021-01-01
    Get full text
    Article

Search Tools: